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Although progress has been recentlymade in understanding of inflammatory bowel diseases (IBD), their etiology is unknown apart
from several factors from adipose tissue and skeletal muscles such as cytokines, adipokines, and myokines were implicated in the
pathogenesis of ulcerative colitis. We studied the effect high-fat diet (HFD; cholesterol up to 70%), low-fat diet (LFD; cholesterol
up to 10%), and the normal diet (total fat up to 5%) in rats with TNBS colitis forced to treadmill running exercise (5 days/week)
for 6 weeks. In nonexercising HFD rats, the area of colonic damage, colonic tissue weight, the plasma IL-1𝛽, TNF-𝛼, TWEAK,
and leptin levels, and the expression of IL-1𝛽-, TNF-𝛼-, and Hif1𝛼 mRNAs were significantly increased and a significant fall in
plasma adiponectin and irisin levels was observed as compared to LFD rats. In HFD animals, the exercise significantly accelerated
the healing of colitis, raised the plasma levels of IL-6 and irisin, downregulated the expression of IL-1𝛽, TNF-𝛼, and Hif1𝛼, and
significantly decreased the plasma IL-1𝛽, TNF 𝛼, TWEAK, and leptin levels. We conclude that HFD delays the healing of colitis in
trained rats via decrease in CBF and plasma IL-1𝛽, TNF-𝛼, TWEAK, and leptin levels and the release of protective irisin.
1. Introduction
Inflammatory bowel diseases (IBD) such as ulcerative colitis
(UC) and Crohn’s disease (CD) are characterized by chronic
relapsing inflammation of the gastrointestinal (GI) tract.
Their etiology still remains unknown and it is believed that
a combination of environmental agents and a dysfunctional
mucosal immune system in genetically susceptible individu-
als could play an important role in their development [1, 2].
The composition of the gut microbiome could be an impor-
tant environmental factor in IBD and a number of studies
suggested a mucosal immune response to commensal bacte-
ria in the pathogenesis of IBD and particularly in CD. The
typical inflammatory response starts with an infiltration of
neutrophils and macrophages known to release a variety
of cytokines and chemokines that aggravate the immune
response. It was established that CD is a Th1 cytokine-medi-
ated disease characterized by increased production of inter-
feron- (IFN-) 𝛾, while UC bears a resemblance to a modified
Th2 profile, with an augmented release of interleukin- (IL-)
5 but normal IFN-𝛾 production [3]. Cytokines, such as
TNF-𝛼, IL-1𝛽, and IL-6, that are more promiscuous in their
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function, are associated with both forms of IBD to a lesser
or greater degree [3, 4]. Each of these cytokines activates
NF-𝜅B and the mitogen-activated protein (MAP) kinases
and induces various “downstream” proinflammatory effects
responsible for the tissue and organ pathology in IBD [3].
Epidemiological studies have indicated that the incidence and
prevalence of IBD rapidly increased particularly in Western
countries and the rise observed in the rest of the world closely
correlates with adopting aWestern lifestyle including dietary
habits, physical inactivity, and obesity [5]. Although the
majority of CDpatients are undernourished, there is now evi-
dence that increasing bodymass index (BMI) and overweight
are emerging features of CD andmay be associatedwithmore
severe course of disease activity [6, 7]. In Crohn’s disease-
relevant mouse model, the high-fat diet feeding actually
accelerated the intestinal inflammation [8]. Characteristic
feature for CD is hypertrophy of the mesenteric fat tissue
located around the inflamed parts of the intestine [9]. Recent
research suggests that this fat wrapping contributes actively
to disease severity and may influence onset of complica-
tions [10–17]. This mesenteric fat is present from the onset
of disease and is associated with overexpression of TNF-𝛼,
leptin, and other adipokines and correlates with the severity
of intestinal inflammation and tissue injury, suggesting an
important role for adipose tissue in the intestinal inflam-
matory process in CD [9]. Well-documented observations
that physical activity is correlated inversely with systemic
low-level inflammation lead to the suggestion that the anti-
inflammatory activity induced by regular exercise may be
responsible for some beneficial health effects in patients with
chronic diseases including IBD [18]. Exercise may exert its
anti-inflammatory effect via a reduction in visceral fat mass
and/or by induction of an anti-inflammatory environment
with each bout of exercise. Such effects may in part be medi-
ated viamuscle-derived peptides, so-called “myokines” [19].
While no single animal model fully captures the clinical
and histopathological features of human IBD, the 2,4,6-tri-
nitrobenzenesulfonic acid- (TNBS-) induced colitis is believed
to be the most relevant to study CD-related immune
responses [20]. The intrarectal administration of TNBS hap-
ten reagent in ethanol solution causes disruption of the
epithelial layer and exposes the lamina propria to bacte-
rial and host haptenized protein. The experimental colitis
induced by TNBS has many of the typical features of CD
including the severe transmural inflammation, diarrhea,
weight loss, and induction of IL-12-driven inflammation with
amassiveTh-1-mediated response [20]. In rodentwithTNBS-
induced colitis, a characteristic reduction of food intake and
loss of weight together with a decrease in skeletalmusclemass
associatedwith the severity of colitis have been described [21].
Our present study was designed to determine the effect
of moderate forced treadmill on experimental colitis caused
by intrarectal administration of TNBS in rats fed normal,
low-fat, or high-fat diet. We hypothesized that diet-induced
obesity augments the severity of experimental colitis and that
the possible beneficial effects of physical exercise contrib-
ute to healing of colitis by modifying muscle-adipose tissue
crosstalk. This particular issue has not been so far closely
elucidated in relation to different diets and the possible
alterations in plasma levels of myokines and adipokines and
the expression of proinflammatory factors (cytokines and
hypoxia inducible factor-1 alpha) considered as markers of
inflammatory reactions associated with development and
healing of colitis.
2. Material and Methods
2.1. Studies in AnimalModel. Animal studies were carried out
on eightymaleWistar rats 200–220 gwith free access to water
and food and adapted to laboratory conditions and 12/12 h
day/night cycles. The study was approved by the local Ethical
Committee at the Jagiellonian University Medical College in
Cracow, Poland, and run in accordance with the Helsinki
declaration.
One hundred twenty animals were randomized into the
three experimental series (A–C) and fed for 8 weeks with
either (A) high-fat diet (HFD; cholesterol up to 70%), (B)
low-fat diet (LFD; cholesterol up to 10%), or (C) normal
rodent diet (C1000 containing less than 5% of total fat), all in
form of regular chow pellets and availability of tap water. All
rodent diets were purchased from Altromin Company, Lage,
Germany.
2.2. Forced Treadmill Exercise Training. Animals (series A–
C) were randomly assigned to exercise groups and were
subjected to running on a two-lane treadmill (Harvard Appa-
ratus, MA, USA) at a speed of 20m/min for 30min each day,
5 days/week (total of 6 wks), prior to development of colitis.
The treadmill used in our study has an endless conveyor-
type belt, driven by a DC servomotor with optical encoder
for precise speed control. The animals were separated from
each other by opaque partitions. The motor drive electronics
permits the user to select any speed from 0 up to 100m per
min. The front of the treadmill is made of dark acrylic so
that the animals can run towards the darkened section of the
channel.
After 6 weeks of exercise training, the colitis was induced
in groups of trained and untrained rats fed different diets by
intracolonic administration of 2,4,6-trinitrobenzenesulfonic
acid (TNBS, Sigma, Slough, UK) at a dose of 10mg/kg, dis-
solved in 50% solution of ethanol as reported in our previous
studies [22, 23]. Briefly, the animals were anaesthetized with
phenobarbital (60mg/kg i.p.) and TNBS was administered
into the colon in a volume of 0.25mLper rat at a depth of 8 cm
from the rectum with the use of a soft polyethylene catheter.
Until the moment of awakening, the rats were positioned in
the Trendelenburg position so as to avoid loss of the TNBS
solution via rectum. Animals in the control group were given
0.9% saline in a volume of 0.25mL per rat, corresponding
to the rats that were administered TNBS. Following the
induction of colitis, animals were housed individually, and
daily food intake and body weight were monitored. With
the induction of colitis, the exercise sessions have stopped.
At day 14 from induction of colonic lesions with TNBS, the
animals were weighed and anaesthetized to determine CBF
using the H
2
-gas clearance technique. The abdominal cavity
was opened and, after separation of the colon, the CBF in
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the areas of the mucosa not affected by inflammatory lesions
was measured. CBF was expressed as a percentage of the CBF
in the vehicle-control rats without TNBS administration as
reported by our group elsewhere [22].
The area of colonic damage were evaluated planimetri-
cally (Morphomat, Carl Zeiss, Berlin, Germany) by two inde-
pendent researchers. Subsequently, fragments of the colon
(2mm × 10mm) with colonic lesions were sampled, fixed
with formaldehyde, embedded in paraffin, and routinely
stained with haematoxylin and eosin (H&E) for histolog-
ical assessment. The presence and intensity of histological
changes were evaluated for the following criteria: presence,
area, and depth of ulceration and presence and intensity
of inflammatory infiltrations, ulcerations, and fibrosis. The
microscopic changes in the colonic mucosa were graded with
a compounded histological score including the extent of (1)
crypt damage, (2) regeneration, (3) metaplasia/hyperplasia,
(4) lamina propria vascular changes, (5) submucosal changes,
and (6) presence of inflammatory infiltrates. The sections
were graded with a range from 0 to 4 for each of the pre-
vious categories and data were analyzed as a normalized
compounded score [22, 23].
2.3. Determination of Plasma Cytokines and MPO Activity.
Immediately after the CBF measurements, a venous blood
sample was drawn from the vena cava and placed into EDTA-
containing vials and used for the determination of plasma
IL-1𝛽, TNF-𝛼, TWEAK, IL-6, leptin, adiponectin, and irisin
levels. Briefly, blood was collected and placed into sterile,
plastic syringes and kept in ice till centrifugation. The blood
samples were centrifuged with the speed of 1000G for 10
minutes in 15∘C temperature and the plasma was stored in
−80∘C. The plasma TNF-𝛼, IL-1𝛽, TWEAK, IL-6, leptin,
and adiponectin were determined by a solid phase sandwich
ELISA (BioSource International Inc., Camarillo, CA, USA)
according to the manufacturer’s instructions [24]. Plasma
irisin protein concentrations were measured using a specific
ELISA kit (Phoenix Pharmaceuticals Inc., USA). The frag-
ments of colonic tissue weighing about 200mgwere collected
and frozen in−70∘C for the determination ofMPO activity by
ELISA as reported previously [25].
2.4. Expression of IL-1𝛽, TNF-𝛼, and Hif1𝛼 Transcripts in the
Rat Colonic Mucosa Determined by Reverse Transcriptase-
Polymerase Chain Reaction (RT-PCR). The mRNA expres-
sion for IL-1𝛽, TNF-𝛼, and Hif1𝛼 was determined by RT-
PCR in the unchanged colon mucosa of intact rats or those
with TNBS colitis fed with different diets. Biopsy samples
of colonic mucosa weighing about 200mg were scraped off
fromoxynticmucosa using a slide glass and immediately snap
frozen in liquid nitrogen and stored at −80∘C until analysis.
The total RNA was extracted from the mucosal samples by a
guanidium isothiocyanate/phenol chloroform method using
a kit from Stratagene (Heidelberg, Germany) according to
methods described by Chomczynski and Sacchi [26]. The
concentration of RNA in RNase-free Tris-EDTA buffer was
measured at absorption of 260 nm wavelengths by spectro-
photometry. Five 𝜇g of total cellular RNA single-stranded
cDNA was generated using StrataScript reverse transcriptase
and oligo(dT) primers (Stratagene). The polymerase chain
reaction mixture was amplified in a DNA thermal cycler
(Perkin-Elmer-Cetus, Norwalk, CT).The nucleotide sequen-
ces of the primers used in PCR were as follows: 𝛽-actin (size
of PCR product 764 bp), forward: 5󸀠-TTG TAA CCA ACT
GGG ACG ATA TGG-3󸀠, reverse: 5󸀠-GAT CTT GAT CTT
CATGGTGCTAGG-3󸀠; IL-1𝛽 (size of PCR product 543 bp),
forward: 5󸀠-GCT ACC TAT GTC TTG CCC GT-3󸀠, reverse:
5󸀠-GAC CAT TGC TGT TTC CTA GG-3󸀠; TNF-𝛼 (size of
PCR product 295 bp), forward: 5󸀠-TACTGAACTTCGGGG
TGA TTG GTC C-3󸀠, reverse: 5󸀠-CAG CCT TGT CCC TTG
AAG AGA ACC-3󸀠; Hif1𝛼 (size of PCR product 510 bp),
forward: 5󸀠-TCT GGA CTC TCG CCT CTG-3󸀠, reverse 5󸀠-
GCT GCC CTT CTG ACT CTG-3󸀠.
PCR products were separated by electrophoresis in 2%
agarose gel containing 0.5𝜇g/mL ethidium bromide and
then visualized under UV light as described previously [23,
24]. The signal intensity of expression of mRNAs for IL-1𝛽,
TNF-𝛼, and Hif1𝛼 was analyzed by densitometry (Gel-Pro
Analyzer, Fotodyne Incorporated, Hartland, WI, USA) [24].
2.5. Statistical Analysis. Results are expressed as means ±
SEM. The data was processed by the statistical analysis soft-
ware SPSS version 16.0 (SPSS Inc., Chicago, IL). Statistical
analysis was done using Student’s 𝑡-test or analysis of variance
and two-way ANOVA test with Tukey post hoc test where
appropriate. Differences of 𝑃 < 0.05 were considered signifi-
cant.
3. Results
3.1. The Effects of Exercise on the Healing Process of Colonic
Lesions and CBF in Rats Fed with Different Diet. As shown
in Figure 1, the intrarectal administration of TNBS in rats
induced severe mucosal injury characterized by necrosis of
the epithelium and focal ulcerations of the mucosa in rats
fed with normal diet. This colonic damage was significantly
aggravated in rats with HFD (𝑃 < 0.05) and also significantly
increased in those fed with LFD. The CBF was significantly
decreased in HDF and LDF rats (𝑃 < 0.05) as compared with
those fed with normal diet. In rats subjected to exercise prior
to administration of TNBS, a significant reduction in the area
of colonic lesions (𝑃 < 0.05) and a significant increase in CBF
(𝑃 < 0.05) were observed as compared to those recorded in
sedentary animals with TNBS colitis (Figure 1).
Figures 2(a), 2(b), 2(c), and 2(d) show the macroscopic
appearance of the intact colonic mucosa (a) and that with
TNBS colitis in rats fed with normal diet (b) or HFD without
exercise (c) or HFD with exercise (d). The intact colonic
mucosa showed normal macroscopic appearance but, in
rats administered with TNBS, the severe colonic damage as
manifested by the area of mucosal damage was observed and
this damage was markedly exacerbated in rats fed with HFD
(Figure 2(b) versus Figure 2(c)). In TNBS rats fed HFD and
subjected to exercise, the area of colonic lesions was reduced
comparing to that observed in TNBS rats fed HFD without
exercise training (Figure 2(d) versus Figure 2(c)).
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Figure 1: Effect of exercise on the area of colonic lesions and the
alterations in CBF in animals fed normal diet, high-fat diet (HFD),
and low-fat diet (LFD). Results are mean ± SEM of 8 animals per
each group. An asterisk indicates a significant change (𝑃 < 0.05) as
compared to respective values in rats fed normal diet. Cross indi-
cates a significant change (𝑃 < 0.05) as compared to the respective
values obtained in animals fed different diets but not subjected to
exercise.
Figures 3(a), 3(b), 3(c), and 3(d) show that the representa-
tive colonic tissue pathomorphologic changes were evidently
more severe in rats with TNBS colitis fed normal diet or those
with TNBS colitis fed HFD compared with intact colonic
mucosa. The histological appearance of mucosa of rat fed
normal diet was illustrated by a desquamation of colonic
epithelium and deep ulcerations reachingmuscularis mucosa
followed by neutrophil infiltration. In HFD rats, there was a
total disorganization of mucosal structure, deep ulceration
with necrosis, and heavy inflammation followed by intense
infiltration with neutrophils, fibrosis, and lesser regeneration
comparing with rats fed with normal diet. In contrast, the
less pronounced histologic changes and neutrophil infil-
tration were observed in HFD rats subjected to exercise
as manifested by the partial restoration of colonic mucosa
architecture, amore pronounced regeneration, and the lack of
deep mucosal ulcerations indicating more advanced healing
of colonic mucosa compared with that in sedentary HFD rats
without exercise (Figure 3(d) versus Figure 3(c)).
3.2. Effect of Exercise on theWeight of Colon andMPOActivity.
As shown in Figure 4, the weight of colonic tissue was not
significantly affected in rats without colitis fed different diets:
either normal diet, HFD, or LFD. However, the weight of
examined colonic tissue was significantly increased in rats
with TNBS-induced colitis fed with normal diet when com-
pared with that measured in rats without colitis (Figure 4).
The weight of colonic tissue in TNBS exercising rats was
significantly decreased in comparisonwith the untrained ani-
mals (Figure 4). Comparing with LFD or normal diet, TNBS
rats subjected to HFD showed the significant increase in the
weight of colonic tissue (𝑃 < 0.05) (Figure 4). MPO activity,
as the marker of neutrophil infiltration of colonic mucosa
which corresponded with the intensity of inflammation, was
significantly increased in the colonic mucosa of TNBS colitis
(𝑃 < 0.02) as compared with MPO activity in rats without
colitis (Figure 4). In HFD rats, a significant elevation ofMPO
activity over the values measured in rats fed both of the
normal diet and LFD (𝑃 < 0.05) was observed. As shown
in Figure 4, in TNBS rats fed HDF and subjected to exercise,
a significant fall of MPO activity (𝑃 < 0.05) in the colonic
mucosa comparing with group of sedentary rats fed different
diets was recorded.
3.3. Effect of Exercise on Plasma Proinflammatory Cytokines
IL-1𝛽, TWEAK, and TNF-𝛼 Levels. Plasma levels of proin-
flammatory cytokines IL-1𝛽, TWEAK, and TNF-𝛼 were
significantly elevated in animals with TNBS-induced colitis
(𝑃 < 0.02) in comparison with intact rats (Figure 5). In rats
fed with HFD, a significant increase in plasma IL-1𝛽, TNF-𝛼,
and TWEAK levels (𝑃 < 0.05) was observed comparing to
normal and LFD group. In exercising TNBS rats, a significant
attenuation in plasma levels of proinflammatory cytokines
IL-1𝛽, TNF-𝛼, and TWEAK was observed (𝑃 < 0.05) as
compared to the values of these cytokines in sedentary rats
fed with different diets. However, there were no significant
differences between HFD, LFD, and normal diet groups in
plasma levels of IL-1𝛽, TNF-𝛼, and TWEAK in TNBS-rats
subjected to exercise (Figure 5).
3.4. Effect of Exercise on Plasma Adipokine Leptin and Adi-
ponectin Levels. Plasma level of leptin was significantly ele-
vated and the plasma adiponectin level was significantly
decreased in animals with TNBS-induced colitis fed normal
diet (𝑃 < 0.05) comparing with those measured in intact
animals (Figure 6).HFD significantly increased plasma leptin
level and significantly decreased the plasma adiponectin
levels (𝑃 < 0.05) as compared to values obtained in rats
fed either normal diet or LDF (Figure 6). Exercise signifi-
cantly decreased plasma levels of leptin and also significantly
increased the plasma adiponectin levels in rats fed HFD (𝑃 <
0.05) as compared to the values of this adipokine recorded in
untrained rats.
3.5. Effect of Exercise on PlasmaMyokine Irisin and IL-6 Levels
in Rats with TNBS Colitis Fed Different Diets with or without
Exercise. As shown in Figure 7, the plasma levels of irisin and
IL-6 were not significantly altered in TNBS rats fed normal
diet as compared with intact rats. However, in TNBS colitis
rats fed with HFD, the plasma levels of irisin and IL-6 were
significantly decreased (𝑃 < 0.05) as compared with those
fed LFD. Exercise significantly increased plasma levels of
irisin and IL-6 (𝑃 < 0.05) in TNBS rats fed normal diet,
HFD, and LFD comparing to those recorded in sedentary rats
(Figure 7).
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(a) (b) (c) (d)
Figure 2:The representativemacroscopic appearance of intact colonicmucosa (a) and the colonicmucosa of rat with TNBS colitis fed normal
diet (b) orHFDwithout exercise (c) andHFDwith exercise (d) at day 14 after TNBS induction.Note, the normal appearance of colonicmucosa
(a) and the severe colonic damage in TNBS rat fed normal diet (b). This damage was exacerbated in untrained rat fed HFD as reflected by
necrotic damage occupying larger area of colonic mucosa (c). However, in trained rat fed HFD, the colonic damage was reduced and smaller
area of the colonic damage was clearly confirmed by gross inspection (d).
(a) (b)
(c) (d)
Figure 3: The histological appearance of colonic mucosa of intact rat (a) and the colonic mucosa of rat with TNBS colitis fed normal diet
(b) or fed HFD without exercise (c) and HFD with exercise (d) at day 14 after TNBS induction. Note the normal architecture of the colonic
crypts in intact rat (a) and the severe damage as manifested by a partial loss of normal architecture and deep ulceration reaching muscularis
mucosa (b).This histological damage was potentiated in untrained rat fed HFD showing complete loss of architecture accompanied by severe
inflammation (c). In contrast, in trained rat fed HFD, both the area of colonic damage and the inflammatory reaction were reduced andmore
regeneration around the ulceration was evidently seen (d).
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Figure 6: The effect of exercise on the plasma levels of leptin and
adiponectin in trained and untrained rats fed normal diet, HFD, or
LFD. Results are mean ± S.E.M. of seven animals per each experi-
mental group. Asterisk indicates a significant change (𝑃 < 0.05) as
compared with respective values in intact rats. Asterisk and cross
indicate a significant change (𝑃 < 0.05) as compared with respective
values in animals fed with normal diet or LFD. Cross indicates a
significant change (𝑃 < 0.05) as compared with those obtained in
untrained animals.
3.6. Effect of Exercise on the Mucosal Expression of 𝛽-Actin,
IL-1𝛽, TNF-𝛼, and Hif1𝛼 in Rats with TNBS Colitis Fed HFD
or LFD with or without Exercise. Figures 8(A)–8(D) show
the effect of HFD alone or HFD and LFD with exercise on
the mRNA expression of proinflammatory cytokines IL-1𝛽
andTNF-𝛼 and proinflammatorymarkerHif1𝛼 in the colonic
mucosa of rats with TNBS-induced colitis fed different diets.
The weak signals for expression of IL-1𝛽, TNF-𝛼, and Hif1𝛼
mRNAs were recorded in intact mucosa (Figures 8(B), 8(C),
and 8(D)). In untrained rats fed HFD, the signal intensity
for these factors was significantly enhanced compared to
that observed in the intact colonic mucosa (Figure 8(a)).
This increase in signal intensity observed in rats fed HFD
without exercise was significantly inhibited in trained rats
fed HFD. The semiquantitative ratio of IL-1𝛽-, TNF-𝛼-, and
Hif1𝛼mRNAs over 𝛽-actin mRNA confirmed that the IL-1𝛽,
TNF-𝛼, andHif1𝛼mRNAswere upregulated in TNBS rats fed
HFD as compared with the expression of mRNA for these
factors detected in intact colonic mucosa (Figure 8(b)). The
signal intensity of mRNAs expression of IL-1𝛽, TNF-𝛼, and
Hif1𝛼 in rats fed HFD or LFD was significantly inhibited
in those subjected to exercise. The ratio of mRNAs for IL-
1𝛽, TNF-𝛼, and Hif1𝛼 over 𝛽-actin mRNA confirmed that
the expression of mRNAs for IL-1𝛽, TNF-𝛼, and Hif1𝛼 was
significantly decreased in TNBS rats subjected to exercise
(Figures 8(a) and 8(b)).
4. Discussion
The results of our present study indicate that diet-induced
obesity delayed the healing of experimental colitis in rats and
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Figure 7:The effect of exercise on the plasma levels of irisin and IL-6
in trained and untrained rats fed normal diet, HFD, or LFD. Results
are mean ± SEM of eight animals per each experimental group.
Asterisk indicates a significant change (𝑃 < 0.05) as compared with
respective values in intact rats. Cross indicates a significant change
(𝑃 < 0.05) as compared with those obtained in animals not sub-
jected to exercise.
that the forced moderate treadmill running 6 weeks prior
to colitis induction significantly attenuated the severity of
colonic damage induced by colonic application of TNBS in
these rats. The mechanism of a beneficial effect of exercise
observed in our study should be further elucidated but we
found that this effect could be attributed to exercise-induced
increase in the CBF and the release of myokines that can
attenuate the gross, histological, and functional changes in
the inflamed colon leading to an improvement in themucosal
healing of colitis. The development of experimental colitis in
HFD rats was accompanied by the fall in CBF, the increased
expression of proinflammatory cytokines IL-1𝛽, TNF-𝛼, and
TWEAK, and decreased release of protective adipokines (e.g.,
adiponectin). All of these alterations possibly contributed to
the exacerbation of colitis in these rats when compared to
those that were fed a normal diet or low fat diet. We provide
evidence that exercise applied prior to the development of
colitis, especially in rats with diet-induced obesity as reflected
by an increase in weight of colonic tissue and increasedMPO
activity, resulted in an enhancement in colonic microcircula-
tion as a conglomeration of an increase in CBF, lower colonic
tissue weight, an increase of MPO content, and the increased
plasma levels of protective myokines, irisin, and IL-6. More-
over, exercise attenuated the expression of proinflammatory
cytokines IL-1𝛽 and TNF-𝛼 and their plasma levels, as well
as the expression of inflammatory state and cytokines of the
colonic mucosa as well as Hif1𝛼, in rats subjected to HFD,
which suggested that moderate exercise selected in our study
exerts a beneficial influence on the healing of colonic mucosa
in this rodent model of colitis.
It is now generally accepted that obesity represents a low-
grade chronic inflammatory state, characterized by abnormal
profile of cytokine secretion, increased synthesis of acute-
phase reactants, such as C-reactive protein (CRP), and the
activation of proinflammatory signaling pathways [27]. Adi-
pocytes are now recognized as new members of the immune
system, producing several cytokines such as IL-6, TNF-𝛼, and
chemokines, in addition to adipokines (leptin, adiponectin,
and resistin) [28, 29]. Abdominal adiposity and especially
mWAT has been implicated in a wide range of gastroin-
testinal disorders from fatty liver and GI cancers to acute
pancreatitis and Crohn’s disease (CD) [30]. Furthermore, the
macrophages infiltrate adipose tissue during obesity, thus
contributing to production and release of additional inflam-
matory mediators [31], and the adipose tissue depots can be
altered due to inflammatory pathologies such as CD [11, 14,
28]. Interestingly, CDhas not necessarily been associatedwith
obesity and is characterized by hypertrophy of mesenteric
adipose tissue [14]. Several mechanisms could be responsible
for a link of general or local obesity with CD. In genetically
obese mice, the increased intestinal permeability has been
described and considered one of themajor pathogenic mech-
anisms linked with CD and UC [19].
In the normal intestinal mucosa, a continuous low-grade,
nonpathogenic inflammation is observed, and this is trig-
gered by a perpetual exposure of intestinal mucosa to a
marked antigenic load from dietary and microbial antigens
and several ligands of toll-like receptors (TLRs) [32]. Despite
the lamina propria infiltration with activated immune cells,
the IBD might be developed due to disruption or weaken-
ing of the mucosal barrier and recognition of the normal
microbiota as pathogens [32]. Both CD and UC patients
exhibited the activation of innate (macrophage, neutrophils)
and acquired (T and B cell) immune responses and loss of
tolerance to enteric commensal bacteria [33]. Fat wrapping
and mesenteric adipose tissue hypertrophy are consistent
features recognized on surgical specimens in patients with
CD [9] and recent research suggests that the hypertrophied
fat contributes actively to disease severity and may influence
onset of complications [10–16]. It is likely that the mesenteric
fat in CD is exposed to gut microbial antigens. Adipocytes
express toll-like receptors and CD14, and both were shown
to interact with these microbial antigens activating NF-𝜅B
pathways [34]. About 95% of the total viable bacteria cul-
tured from mesenteric tissues are physiologically located in
adipocytes, and only 5% are translocated inmesenteric lymph
nodes, indicating that adipocytes might be a main reservoir
of bacteria in themesentery. Intriguingly, obesity is associated
with reduced microbial diversity in a similar pattern to that
seen inCD [35, 36]. All these observations fuelled speculation
about the potential roles ofmesentericmWAT in the develop-
ment of CD by reacting to the microbial environment and by
initiating and/or promoting local inflammatory reactions by
autocrine and/or paracrinemodulation of adipocytes [10, 13].
In our study, the impaired healing of TNBS colitis accom-
panied by the reduction in the colonic blood flow was
observed in rats fed HFD compared with rats fed a normal
diet or LFD.These changes were accompanied by increase in
plasma levels of proinflammatory mediators such as IL-1𝛽,
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Figure 8:The RT-PCR analysis of mRNA expression for 𝛽-actin (A), IL-1𝛽 (B), TNF-𝛼 (C), and Hif1𝛼 (D) (a) in colonic mucosa of intact rats
or untrained TNBS rats fed HFD or trained TNBS rats fed HDF or LDF and the semiquantitative ratio of IL-1𝛽-, TNF-𝛼-, and Hif1𝛼mRNAs
over 𝛽-actin mRNA (b). Results are mean ± SEM of 4 determinations. Asterisk indicates a significant change (𝑃 < 0.05) as compared with
the values obtained in intact colonic mucosa. Cross indicates a significant change (𝑃 < 0.05) as compared with untrained rats fed with HFD.
TNF-𝛼, TWEAK, and leptin and the reduction in plasma
adiponectin levels. Particularly interesting to the study, is that
the plasma TWEAK level was increased in rats with TNBS-
induced colitis fed normal diet and this increase was potently
elevated in rats fed HFD. This observation is consistent with
the involvement of TWEAK cytokine in the inflammatory
processes [37]. TWEAK actions are mediated by its binding
to fibroblast growth factor-inducible 14 (Fn14), a highly indu-
cible cell surface receptor that has been linked to several
intracellular proinflammatory signaling pathways, including
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the NF-𝜅B pathway [17]. An increase in TWEAK and Fn14
gene expression in adipose tissue of severely obese patients
was reported and inflammatory stimuli in vitro differentially
increased the expression of TWEAK in macrophages and
Fn14 in adipocytes [38]. Expression of Fn14 is upregulated in
CD patients [37, 39] and the TWEAK/Fn14 pathway plays a
pathological role inmousemodels of CD by inducing inflam-
matory responses and regulating intestinal epithelial cell
turnover [39–42].
Furthermore, we found that leptin, the product of adipose
tissue, was increased in rats with colitis fed normal diet and
this effect was markedly enhanced in rats fed HFD. This
remains in agreement with previous observation that intesti-
nal leptin, a cytokine produced by adipocytes, is increased in
CD and can upregulate NF𝜅B expression in colonic epithelial
cells leading to development of inflammation [12, 43, 44].
Leptin is considered to be a proinflammatory cytokine and
directly regulates production of several cytokines, partic-
ularly those produced by T cells [12]. An overexpression
of leptin mRNA in mWAT was reported in IBD patients,
indicating that leptin might participate in the inflammatory
process by enhancing mesenteric expression of TNF-𝛼 [45].
Also, in rat model of experimental colitis, an elevated plasma
leptin levels were observed which correlated with the degree
of inflammation [46]. We also observed that LFD feeding
increased the severity of experimental colitis although not to
the same extent as observed in case of HFD.
It is of interest that plasma level of adiponectin was
significantly decreased in HFD animals than in those fed
normal diet or LFD. Adiponectin has a structure similar
to TNF-𝛼 but antagonizes its effects by reducing secretion
and attenuating the biological actions by competing for
the receptor [47]. Conflicting data have been described for
circulating levels of adiponectin in patientswith IBD [48–50].
However, recent observations of lower levels of serum and
mesenteric adiponectin in active CD patients but not those in
remission support the notion of a defective regulation of anti-
inflammatory pathways in CD pathogenesis [48].The altered
balance between proinflammatory and anti-inflammatory
factors (increase in secretion of TNF-𝛼, leptin, and release of
chemoattractant protein-1 (MCP-1)) and decreased produc-
tion of anti-inflammatory factors (e.g., adiponectin) could
contribute tomacrophage accumulation in adipocytes, aswell
as to an inflammatory transformation of the visceral adipose
tissue, leading to the appearance of creeping fat. Moreover,
the depletion of muscle mass and impaired muscle function
are important features of IBD [51].The IBD-related decreased
muscle mass has been attributed to a variety of mechanisms
including decreased nutrient intake, their malabsorption
increased metabolic rate, and the inhibitory effects of inflam-
mation on the growth hormone (GH)/insulin-like growth
factor- (IGF-) I axis [52]. TWEAK has recently been shown
to mediate the skeletal muscle atrophy in a variety of clinical
settings [53]. Gruber et al. [8] observed in CD-relevant
mouse model that HFD feeding, independently of obesity,
accelerated disease onset of intestinal inflammation through
mechanisms involving the increased intestinal permeability
and altered luminal factors, leading to enhanced dendritic cell
recruitment and promotedTh17 immune responses.
The potential benefits of exercise and physical activity in
IBD patients recently raised major interest [54, 55]. Evidence
suggests that the protective effect of exercise may to some
extent be ascribed to its anti-inflammatory effects and/or
specific effects on visceral fat mediated, in part, via muscle-
derived peptides, so-called “myokines” [19, 56]. Presently
identified myokines which exert endocrine, paracrine, or
autocrine effects are LIF, IL-6, IL-7, BDNF, IGF-1, FGF-2,
FSTL-1, and irisin [57]. The dysfunction of several organs
and tissues of the body as well as an increased risk of chronic
inflammatory diseases has been linked with lack of the
endocrine and paracrine functions of the muscle that are not
activated through contractions [57]. Myokines may balance
and counteract the effects of adipokines such as leptin taking
part in crosstalk between skeletal muscle and adipose tissue
[57, 58].
Herewe have shown for the first time that the plasma level
of irisin was diminished in rats with TNBS-induced colitis
fed HFD but not in those fed normal diet or LFD. Exercise
training leads to marked increase in plasma irisin levels
confirming that irisin identified as a putative myokine that is
induced by exercisingmuscles could be involved in themech-
anism of exercise-induced improvement of mucosal healing
of colitis observed in our study. Interestingly, the circulating
levels of irisinwere also negatively associatedwith obesity and
insulin resistance [59]. It was suggested that irisin could be
therapeutic for human metabolic disease, obesity, and other
disorders in which adipose tissue plays pathogenic role, and
the exercise was found to exert beneficial influence [60].
We have also observed significant increases in circulating
myokine IL-6 after exercise training.While typically regarded
as a proinflammatory cytokine, IL-6 appears to mediate also
metabolic effects associated with exercise. Until recently, it
was accepted that the rise in plasma IL-6 level observed
during exercise was a consequence of immune response to
local damage. Today, it is known that muscle is unique in
its ability to produce IL-6 during contraction in completely
TGF-independent mode, which suggests a major role for this
cytokine in a mechanism of regulation of metabolism rather
than for this cytokine acting as an inflammatory mediator.
Our results are in variance with those observed in recent
studies on the effects of exercise training in a mouse model
of colitis [61].Themoderate forced treadmill running exacer-
bated dextran sodium sulfate- (DSS-) induced experimental
colitis while the voluntary wheel running alleviated colitis
symptoms and reduced inflammatory gene expression in
these mice [61]. These contradictory effects of voluntary
and forced exercise could be explained by effect of stress
resulting from the extensive forced exercise in comparison
with voluntary exercise. The differences between the results
of our study and those by Cook et al. [61] could be explained
by differences in experimental model of colitis and the bout
of exercise used in both studies in different animal species.
In the case of rats subjected to exercise, the applied intensity
of forced exercise could be relatively smaller than for mice.
Intensive exercise could lead to transient systemic inflamma-
tion and increased level of proinflammatory cytokines. It is
well known that intensive exercise in humans could cause
nausea, diarrhea, and gastrointestinal bleeding. For instance,
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in marathon runners, the disorder called “runner’s ischemic
colitis” associated with bloody diarrhea, fatigue, and fever has
been described [62].Therefore, the effects of physical exercise
on various immune parameters during the course of IBDmay
depend on type of exercise and its intensity and duration.
Systematic, moderate exercise may be beneficial for IBD
patients with respect to exercise-induced anti-inflammatory
and anabolic mechanisms. In contrast, the acute intensive
exercise may result in a release of proinflammatory cytokines
predominantly in obese individuals leading to exacerbation
of the inflammatory response andworsening of the pathology
of CD [54].
5. Conclusions
Diet-induced obesity delays the healing of experimental coli-
tis via decrease in CBF and the increase in MPO activity and
the expression and release of proinflammatory mediators.
Exercise diminished the severity of colonic damagemediated,
at least in part, by an improvement of colonic microcircu-
lation, the release of myokines such as protective irisin, and
the restoration of adipokine adiponectin.We propose that the
regular exercise could exert a beneficial effect in human IBD
as documented by our translational research and accumu-
lated evidence in experimental rodent colitis. This beneficial
effect of exercise may be mediated by its long-term effects on
abdominal adiposity and the anti-inflammatory environment
that is created by each acute bout of exercise.
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